Ziemssen, Focke 1975-
Focke Ziemssen researcher ORCID ID = 0000-0002-3873-0581
VIAF ID: 60023329 ( Personal )
Permalink: http://viaf.org/viaf/60023329
Preferred Forms
4xx's: Alternate Name Forms (1)
Works
Title | Sources |
---|---|
Anti-Vascular endothelial growth factor therapy impairs endothelial function of retinal microcirculation in colon cancer patients – an observational study | |
Comprehensive Compositional Analysis of the Slit Lamp Bacteriota | |
Effectiveness and safety of ranibizumab in patients with central retinal vein occlusion: results from the real-world, global, LUMINOUS study | |
Erstellung der Grundlagen eines automatisierten Behandlungs-Scores anhand retrospektiver Datenanalyse von Patienten/innen mit Diabetischem Makulaödem | |
A model to quantify the influence of treatment patterns and optimize outcomes in nAMD | |
Mutationsanalyse ausgewählter neuromuskulärer und metabolischer Erkrankungen | |
Off-label-Anwendung von Bevacizumab in der Ophthalmologie | |
Pharmakovigilanz in der Augenheilkunde | |
Pre-analytical parameters affecting vascular endothelial growth factor measurement in plasma: identifying confounders | |
Sekundärerkrankungen bei hoher Myopie |